Annual Congress Berlin 2008

Saturday, 04.10.2008
Sunday, 05.10.2008
Monday, 06.10.2008
Tuesday, 07.10.2008
Wednesday, 08.10.2008

Citations should be made in the following way: Authors. Title. Eur Respir J 2008; 32: Suppl. 52, abstract number.

Material from 2008:

3952 Abstracts
658 Slide presentations
316 Webcasts
96 Handouts
1824 e-posters
316 Multimedia files

Material from 2008: Show

Biomarkers and antibiotic treatment of exacerbations of COPD

Oral Presentation
Chairs: M. Miravitlles (Barcelona, Spain), T. Wilkinson (Timsbury, United Kingdom)

Download all media

Utility of procalcitonin, neopterin, C-reactive protein and MR-proANP measurement in the management of exacerbations in chronic obstructive pulmonary disease A. Lacoma, C. Prat, J. Domínguez, F. Andreo, S. Blanco, M. A. Cuesta, J. Ruiz-Manzano, V. Ausina (Badalona, Madrid, Spain)
Usefulness of inflammatory markers: procalcitonin, neopterin, C-reactive protein and MR-proANP in the follow-up of patients with chronic obstructive pulmonary disease A. Lacoma, C. Prat, J. Domínguez, F. Andreo, S. Blanco, M. A. Cuesta, J. Ruiz-Manzano, V. Ausina (Badalona, Madrid, Spain)
The role of bacterial pathogens in exacerbation of COPD assessed by microbiological method and polymerase chain reaction K. Kolosova, O. Tsvetkova, E. Ilina, M. Atroshkina (Moscow, Russian Federation)
The relation of sputum color to bacterial load in exacerbations of COPD M. Brusse-Keizer, A. Grotenhuis, H. Kerstjens, M. Telgen, J. van der Palen, R. Hendrix, P. van der Valk (Enschede, Groningen, Netherlands)
Prulifloxacin in the treatment of acute exacerbations of COPD (AECOPD) in cigarette smokers G. Biscione, G. Crigna, F. Pasqua, M. Cazzola (Velletri, Rome, Rome, Italy)
Analysis of the efficacy of moxifloxacin for the treatment of bronchial colonization in COPD patients using microbial molecular typing: a randomized, double-blind, placebo-controlled study A. Marin-Tapia, E. Monsó, L. Millares, M. García, M. Miravitlles, C. de la Roza, R. Hervás, S. Vila, C. Esquinas, A. Torres, J. Morera (Badalona, Barcelona, Spain)
*Clinical significance of aspergillus* isolation from respiratory samples in severe COPD patients. Usefulness of Ascioglu‘s criteria** M. Sancho, M. Gallego, C. Monton, D. Mariscal, A. Moreno, X. Pomares, A. Marin (Sabadell (Barcelona), Spain)
Clinical features of chronic pulmonary aspergillosis treated with voriconazole in patients with chronic respiratory disease E. Hagiwara, A. Sekine, T. Sato, T. Baba, T. Shinohara, T. Endo, Y. Sogo, R. Nishihira, S. Komatsu, Y. Matsumoto, T. Ogura, H. Takahashi (Yokohama, Japan)